BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12595614)

  • 1. Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis.
    Flores-Suárez LF; Cabiedes J; Villa AR; van der Woude FJ; Alcocer-Varela J
    Rheumatology (Oxford); 2003 Feb; 42(2):223-9. PubMed ID: 12595614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
    Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
    Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E; Ahlquist D; Ullrich S; Gross WL
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
    Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S
    J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
    Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
    Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
    Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
    J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.
    Aslam A; Newman TL; Misbah SA
    J Clin Pathol; 2003 Oct; 56(10):775-7. PubMed ID: 14514783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of commercial and in-house ELISAs for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase.
    Pollock W; Dunster K; Rolland JM; Koh H; Savige J
    Pathology; 1999 Feb; 31(1):38-43. PubMed ID: 10212921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
    Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
    Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
    Paspaliaris B; Pamio M; Savige J
    J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
    Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
    J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation.
    Esquivel-Valerio JA; Flores-Suárez LF; Rodríguez-Amado J; Garza-Elizondo MA; Rendón A; Salinas-Carmona MC
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):35-9. PubMed ID: 20412700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA).
    Wang G; Csernok E; de Groot K; Gross WL
    J Immunol Methods; 1997 Oct; 208(2):203-11. PubMed ID: 9433475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.